Suraksha Diagnostic Limited (SURAKSHA) reported revenue of ₹84.09 Cr and net profit of ₹12.58 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
SURAKSHA fundamentals, Fundamental score 68/100
The statements below are read from Suraksha Diagnostic Limited’s filed results, 7 filed quarters and 9 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 13, 2026 · audited
Sales CAGR · 3Y+16.5%FY22 → FY25
Sales CAGR · 4Y+7.8%FY21 → FY25
PAT CAGR · 3Y+69.5%FY22 → FY25
PAT CAGR · 4Y+9.1%FY21 → FY25
Price · 1Y+9.8%EOD
Price CAGR · 3Y—EOD
Showing standalone — consolidated filings end Q4 FY25-26.
Quarterly resultsStandalone
₹ Cr
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
58.6
64.1
70.3
76.3
75.6
78.6
84.1
+19.6%
40.5
44.3
46.4
52.3
52.4
54.8
55.2
+18.8%
Operating profit
18.1
19.8
23.8
24.0
23.2
23.8
28.9
+21.3%
OPM %
30.9%
30.9%
33.9%
31.4%
30.7%
30.3%
34.4%
+0.5 pp
Other income
0.97
0.94
1.10
0.97
0.99
1.30
1.56
+42.7%
Interest
2.03
2.06
2.66
2.72
3.10
3.87
3.67
+38.0%
Depreciation
8.62
8.66
9.15
9.65
10.1
10.7
10.6
+15.8%
Profit before tax
8.42
10.0
13.1
12.6
11.0
10.6
16.2
+23.6%
Tax %
24.5%
20.3%
24.9%
25.5%
25.8%
36.4%
22.4%
-2.5 pp
Net profit
6.36
8.01
9.85
9.36
8.14
6.71
12.6
+27.8%
EPS (₹)
1.22
1.54
1.89
1.80
1.56
1.29
2.42
+28.0%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 7 quarters
RevenueNet profit
Revenue & net profit — Standalone7 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±3.5%· EPS surprise: no estimates source
Q1'27filed Wed 12 Aug 17:54 · first tradeable session Thu 13 Auggap +3.6%close +12.6%
Q4'26filed Thu 21 May 18:42 · first tradeable session Fri 22 Maygap +0.0%close −2.2%
Q3'26filed Thu 5 Feb 17:00 · first tradeable session Fri 6 Febgap +1.4%close +0.8%
Q2'26filed Mon 10 Nov 16:54 · first tradeable session Tue 11 Novgap −2.5%close −2.8%
Q1'26filed Fri 8 Aug 19:45 · first tradeable session Mon 11 Auggap +0.3%close −0.5%
Q4'25filed Wed 28 May 19:31 · first tradeable session Thu 29 Maygap +0.0%close −2.9%
Q3'25filed Sat 8 Feb 18:20 · first tradeable session Mon 10 Febgap −1.8%close −4.6%
Q2'25filed Fri 20 Dec 19:05 · first tradeable session Mon 23 Decgap +2.4%close −1.9%
